BioSpace News Archive

Deals

Heron Therapeutics Announces Pricing of Public Offering of Approximately $200 Million of its Common Stock

Heron Therapeutics, Inc. announced the pricing of an underwritten public offering of approximately $200 million of shares of its common stock.

June 25, 2018
·
3 min read
Policy

FCF Fishery, Largest Tuna Supplier in Western Pacific, Granted Marine Stewardship Council Certification

FCF Fishery Company (FCF) and the Western Pacific Sustainable Tuna Alliance announced today that the Western and Central Pacific skipjack and yellowfin free school purse seine fishery has been granted Marine Stewardship Council (MSC) Standard for Sustainable Fishing certification.

June 25, 2018
·
2 min read
Policy

GB Sciences Files Patents for Heart Disease and Chronic, Immunological, and Neuropathic Pain

The nonprovisional patent applications protect formulations for pain and heart disease therapies based on myrcene-containing complex mixtures.

June 25, 2018
·
4 min read
Business

DelMar Pharmaceuticals Appoints World-Renowned Molecular Biologist Dr. Napoleone Ferrara to Board of Directors

Dr. Ferrara is a world-renowned molecular biologist in the field of angiogenesis.

June 25, 2018
·
5 min read
Biotech Beach

AntiCancer’s Oral Methioninase Overcomes Gemcitabine Resistance in Patient-Like Mouse Models of Pancreatic Cancer

The new results are to be published in the upcoming issue of Cancer Letters.

June 25, 2018
·
1 min read
Business

AbbVie and Calibr announce collaboration for next generation T-cell therapies

Collaboration will focus on switchable CAR-T therapies aimed primarily at solid tumors

June 25, 2018
·
4 min read
FDA

FDA Accepts Supplemental Biologics License Application for Merck’s KEYTRUDA® (pembrolizumab) as Adjuvant Therapy in Advanced Melanoma

Application Based on Recurrence-Free Survival Data from Pivotal Phase 3 EORTC1325/KEYNOTE-054 Trial

June 25, 2018
·
27 min read
FDA

Glaukos Announces FDA Approval for the iStent inject® Trabecular Micro-Bypass System

Next-Generation Device from MIGS Pioneer Offers Ophthalmic Surgeons a Compelling New Treatment Option for Managing Glaucoma Patients’ IOP

June 25, 2018
·
9 min read
Business

Aerpio Announces Exclusive License Agreement with Gossamer Bio for AKB-4924, a First in Class Hypoxia-Inducible Factor-1 Alpha Stabilizer in Development for Inflammatory Bowel Disease

The arrangement combines Aerpio’s deep understanding of HIF biology with Gossamer’s experience in inflammation, immunology and inflammatory bowel disease (IBD) drug development.

June 25, 2018
·
5 min read
Drug Development

Oramed Enrolls First Patient in Its Glucose Clamp Study for Oral Insulin

Study will provide additional metabolic data on ORMD-0801 in patients with type 1 diabetes

June 25, 2018
·
3 min read